Expert Interview
A Second Look: Discussing the data from two recent presentations on HNSCC from ASCO 2023: PDS Biotech's PDS0101 and Bicara Therapeutics' BCA101.
Ticker(s): PDSB, Bicara TherapeuticsInstitution: Yale
- Professor of Medicine (Medical Oncology) at the Yale University School of Medicine and Yale Cancer Center.
- Co-Leader of the Developmental Therapeutics Program and Clinical Research Program Leader for Head and Neck Cancer.
- Internationally recognized for her research in head and neck cancer. She chairs the Eastern Cooperative Oncology Group Head and Neck Cancer Committee and leads national and international trials of targeted therapy in head and neck cancer.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.